Ocugen (OCGN) Gains from Investment Securities (2016 - 2019)
Ocugen's (OCGN) quarterly Gains from Investment Securities came in at $5000.0 in Q2 2019, up 100.14% YoY from $2498.2 in Q2 2018, and down 99.64% on a QoQ basis from $1.4 million in Q1 2019.
Analysis
Ocugen (OCGN) Gains from Investment Securities (2016 - 2019) Analysis & Trends
Ocugen (OCGN) has 4 years of Gains from Investment Securities data on file, last reported at $5000.0 in Q2 2019.
- Quarterly Gains from Investment Securities rose 100.14% year-over-year to $5000.0 in Q2 2019, while the trailing twelve-month figure through Jun 2019 was -$24.4 million (down 486.11% YoY) and the FY2018 annual result came in at -$20.6 million, down 1490.08% from the prior year.
- Gains from Investment Securities eased to $5000.0 in Q2 2019, from $1.4 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.8 million in Q1 2018 to a low of -$17.8 million in Q3 2018.
- A 4-year average of -$2.9 million and a median of $70000.0 in 2017 frame the typical range for Gains from Investment Securities.
- The widest YoY moves for Gains from Investment Securities: up 3153.9% in 2018, down 6708.18% in 2018.
- Tracing OCGN's Gains from Investment Securities over 4 years: stood at -$17.0 million in 2016, then soared by 104.77% to $809000.0 in 2017, then plunged by 1098.39% to -$8.1 million in 2018, then soared by 100.06% to $5000.0 in 2019.
- The last three Gains from Investment Securities figures came in at $5000.0 (Q2 2019), $1.4 million (Q1 2019), and -$8.1 million (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Ocugen | 458.91 Mn | 358.81 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | 5,000.00 |
| Mar 31, 2019 | 1.41 Mn |
| Dec 31, 2018 | -8.08 Mn |
| Sep 30, 2018 | -17.78 Mn |
| Jun 30, 2018 | -3.50 Mn |
| Mar 31, 2018 | 8.75 Mn |
| Dec 31, 2017 | 809,000.00 |
| Sep 30, 2017 | 269,000.00 |
| Jun 30, 2017 | 135,000.00 |
| Mar 31, 2017 | 269,000.00 |
| Dec 31, 2016 | -16.97 Mn |
| Sep 30, 2016 | -539,000.00 |